Key facts
- This page summarizes William DeVaul's Form 4 filing for Morphic Holding, Inc..
- 7 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 17 Jan 2024, 19:00.
William DeVaul - 12 Jan 2024 Form 4 Insider Report for Morphic Holding, Inc.
- Reporting relationship
- General Counsel and Secretary
- Issuer ticker
- N/A
- Reported as of
- 12 Jan 2024
- Net transaction value
- -$123,956
- SEC form
- 4
- Accepted by SEC
- 17 Jan 2024, 19:00:45 UTC
- Prior SEC filing
- 09 Jun 2023
- Next SEC filing
- 10 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Farrell as attorney-in-fact for William DeVaul
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William DeVaul filed Form 4 for Morphic Holding, Inc. on 17 Jan 2024.
Change
- Previous filing in this sequence was filed on 09 Jun 2023.
- Current net transaction value: -$123,956.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MORF
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +10,950
- Change %
- +82%
- Price
- $0.000000
- Shares after
- 24,288
- Date
- 13 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
MORF
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,250
- Change %
- +13%
- Price
- $0.000000
- Shares after
- 27,538
- Date
- 14 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
MORF
transaction
Common Stock
Sale
- Transaction value
- $123,956
- Shares
- -4,509
- Change %
- -16%
- Price
- $27.49
- Shares after
- 23,029
- Date
- 16 Jan 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MORF
transaction
Derivative
Stock Option (right to buy Common Stock)
Award
- Transaction value
- $0
- Shares
- +69,600
- Change %
- Price
- $0.000000
- Shares after
- 69,600
- Date
- 12 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 69,600
- Exercise price
- $27.79
- Footnotes
- F3
MORF
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +44,400
- Change %
- Price
- $0.000000
- Shares after
- 44,400
- Date
- 12 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,400
- Exercise price
- Footnotes
- F1, F4
MORF
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -10,950
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 32,850
- Date
- 13 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,950
- Exercise price
- Footnotes
- F1, F5
MORF
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -3,250
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 6,500
- Date
- 14 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,250
- Exercise price
- Footnotes
- F1, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
Footnote F2
The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Footnote F3
The option vests as to 2.0833% of the total shares monthly, beginning February 12, 2024, with 100% of the total shares vested and exercisable on January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
Footnote F4
The RSUs vest as to 25% of the total shares on each of January 12, 2025, January 12, 2026, January 12, 2027 and January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
Footnote F5
The RSUs vest as to 25% of the total shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
Footnote F6
The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025 and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.